Theanine.

Caffeine blocks adenosine to raise alertness, while theanine promotes alpha brain wave activity, the calm but wakeful state. Together they support focused attention and steady alertness while theanine softens the jittery, wired edge caffeine alone can bring, which is why the two occur together naturally in tea.

Tyrosine is the raw material the body converts into dopamine and noradrenaline, topping those signals back up when demanding mental work draws them down, while theanine keeps arousal smooth and calm. Formulators pair them so focus stays sharp without tipping into overstimulation, each covering a different side of the attention equation.

Caffeine antagonises adenosine receptors for alertness while theanine raises alpha-band activity and reduces the restless feel. The combination is standard in focus formulas.

Magnesium sits in the NMDA receptor channel and acts as a cofactor in GABA handling, while theanine works on glutamatergic tone and cortical rhythm. The two calming routes are separate.

Melatonin signals biological night through its own receptors while theanine lowers arousal without acting on the clock. Formulas pair a timing signal with a calming one.

Theanine is the tea leaf's own amino acid and sits alongside catechins and caffeine in green tea extract. Adding it restores the leaf ratio in a catechin-heavy extract.

Shade-grown matcha is naturally high in theanine as well as caffeine, which is why its lift reads as smooth. Supplemental theanine acts on that same axis.

Tyrosine feeds dopamine and noradrenaline synthesis while theanine lowers arousal and raises alpha activity. The pairing aims at drive without edginess.

Glycine is an inhibitory neurotransmitter in its own right and lowers core temperature in the evening, while theanine reduces arousal. Both point the same way at night.

Tryptophan supplies the serotonin and melatonin route while theanine acts on arousal by a different mechanism. The two cover separate steps in a wind-down formula.

Apigenin binds at the benzodiazepine site on GABA-A receptors, which theanine does not. Stacking them layers two independent calming mechanisms.

Rosmarinic acid slows GABA breakdown by inhibiting GABA transaminase. Theanine acts on glutamatergic tone instead, so the routes do not overlap.

Honokiol and magnolol positively modulate GABA-A receptors, a mechanism separate from theanine's. They are combined for that complementarity.

Theanine is a glutamine analogue sharing transport routes and glutaminase handling, so a large glutamine dose competes with theanine uptake. Separate the timing to avoid it.

Theanine enters the brain on the large neutral amino acid carrier leucine also uses. A big leucine load at the same moment lowers theanine entry.

An exploratory human study looked at combined GABA and theanine supplementation with sleep quality questionnaires as the readout. Both compounds are discussed as acting on inhibitory signalling, though orally administered GABA crosses into the brain poorly, which complicates any shared-mechanism story. The pairing is common in sleep formulations and the human data on it remain preliminary.

Theanine and EGCG occur together in Camellia sinensis leaf and reach the body together whenever tea or a whole-leaf extract is consumed. Theanine contributes the calm, non-sedating profile while catechins carry the antioxidant chemistry, so a green tea extract standardised only for EGCG is not interchangeable with isolated theanine. Anyone comparing tea studies to isolated theanine studies is comparing two different exposures.

Glutamate decarboxylase, the enzyme that converts glutamate to GABA, requires pyridoxal 5-phosphate. Theanine is a glutamate analogue that interacts with glutamatergic signalling, so adequate B6 sits upstream of the inhibitory side of that balance. This is cofactor biochemistry rather than a tested combination.

5-HTP is the immediate precursor to serotonin, while theanine has been reported to shift serotonin and dopamine levels in animal work. Pairing them in evening formulations is a formulation convention built on those separate observations, not on a trial of the two together. Confidence stays low for that reason.

Valerian constituents interact with GABA-A signalling and theanine is used for its calming profile, so the two appear together in wind-down blends. Additive sedation is the interaction worth flagging, particularly alongside anything else with a sedating profile. There is no combination trial establishing benefit for the pair.

Passionflower flavonoids are described as acting through GABA-A modulation, and it is frequently combined with theanine in evening products. The combination is convention rather than a tested pairing. Additive drowsiness is the practical consideration.

Apigenin-bearing chamomile preparations and theanine are both used to support a settled evening state, and they are routinely blended. The pairing rests on each component's own literature rather than on studies of the two together. Flagged mainly so additive sedation is not a surprise.

Ashwagandha extracts have been studied for markers of the stress axis such as morning cortisol, while theanine work has focused on subjective calm and attention measures. Products combine them to cover both readouts. No trial has separated what each contributes in the blend.

Rhodiola is used for perceived fatigue during demanding periods and theanine for calm focus, so blends pair a stimulating-leaning botanical with a settling amino acid. The rationale mirrors the caffeine-theanine pairing without the same body of evidence behind it. Read it as formulation logic rather than tested synergy.

Bacopa has a slow-onset profile studied over weeks on memory tasks, while theanine acts within the hour on attention and calm measures. Stacking them covers two different time courses in one product. The pair itself has not been studied.

Taurine is an inhibitory-leaning amino acid that interacts with GABA-A and glycine receptors, and theanine is a glutamate analogue with its own calming profile. Both turn up in energy and focus formulas alongside caffeine. The combination is plausible mechanistically and untested clinically.

Inositol functions in phosphoinositide second-messenger signalling downstream of several neurotransmitter receptors, and it is often blended with theanine in calm-focus products. The connection is at the level of shared signalling architecture, not a demonstrated interaction. Confidence is deliberately low.

Alpha GPC supplies choline for acetylcholine synthesis while theanine works on the glutamate and GABA side of the balance. Nootropic blends pair them to touch two systems at once. There is no combination study, so this stays a formulation rationale.